In 2023, the import of heterocyclic compounds containing a benzothiazole ring to the US was nearly stable compared to previous years. However, there are significant forecasted declines from 2024, starting at $40.027 million and plummeting to $0.490 million by 2028. This represents a dramatic year-on-year decrease: approximately -25% from 2024 to 2025, -33% from 2025 to 2026, -49% from 2026 to 2027, and -95% from 2027 to 2028. The compound annual growth rate (CAGR) from 2024 to 2028 is highly negative, indicating a steep decline over five years.
Future trends to watch for:
- Potential changes in global supply chains affecting availability.
- Potential emergence of regulatory or environmental issues influencing demand.
- Technological advancements that may alter the need for these specific compounds.
